{"id":41213,"date":"2021-11-06T05:53:22","date_gmt":"2021-11-06T09:53:22","guid":{"rendered":"https:\/\/www.eldiario.net\/portal\/?p=41213"},"modified":"2021-11-06T05:53:22","modified_gmt":"2021-11-06T09:53:22","slug":"pildora-antiviral-evita-89-de-hospitalizaciones","status":"publish","type":"post","link":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/","title":{"rendered":"P\u00edldora antiviral evita 89 % de  hospitalizaciones"},"content":{"rendered":"<p>Pfizer dio a conocer su nuevo candidato antiviral oral contra el covid-19 que actualmente se encuentra en investigaci\u00f3n. Seg\u00fan los primeros resultados, Paxlovid redujo en 89 % el riesgo de hospitalizaci\u00f3n o muerte en comparaci\u00f3n con el uso de placebos en adultos de alto riesgo no hospitalizados con coronavirus.<br \/>\nEn el ensayo realizado con 1,219 adultos no vacunados, la compa\u00f1\u00eda report\u00f3 que no se registraron muertes en pacientes que recibieron Paxlovid hasta el corte del d\u00eda 28 del estudio, en comparaci\u00f3n con 10 muertes en pacientes que recibieron un placebo. Como resultado, Pfizer planea enviar sus datos a la FDA de Estados Unidos para su autorizaci\u00f3n de emergencia lo antes posible.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer dio a conocer su nuevo candidato antiviral oral contra el covid-19 que actualmente se encuentra en investigaci\u00f3n. Seg\u00fan los primeros resultados, Paxlovid redujo en 89 % el riesgo de hospitalizaci\u00f3n o muerte en comparaci\u00f3n con el uso de placebos en adultos de alto riesgo no hospitalizados con coronavirus. En el ensayo realizado con 1,219 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":41214,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-41213","post","type-post","status-publish","format-standard","has-post-thumbnail","category-portada"],"acf":{"antetitulo":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia\" \/>\n<meta property=\"og:description\" content=\"Pfizer dio a conocer su nuevo candidato antiviral oral contra el covid-19 que actualmente se encuentra en investigaci\u00f3n. Seg\u00fan los primeros resultados, Paxlovid redujo en 89 % el riesgo de hospitalizaci\u00f3n o muerte en comparaci\u00f3n con el uso de placebos en adultos de alto riesgo no hospitalizados con coronavirus. En el ensayo realizado con 1,219 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/\" \/>\n<meta property=\"og:site_name\" content=\"El Diario - Bolivia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eldiario.bolivia\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-06T09:53:22+00:00\" \/>\n<meta name=\"author\" content=\"Jeanette\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@eldiario_net\" \/>\n<meta name=\"twitter:site\" content=\"@eldiario_net\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jeanette\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/\"},\"author\":{\"name\":\"Jeanette\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/person\\\/634255f275431248bb9faa38296b494a\"},\"headline\":\"P\u00edldora antiviral evita 89 % de hospitalizaciones\",\"datePublished\":\"2021-11-06T09:53:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/\"},\"wordCount\":120,\"publisher\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Portada\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/\",\"name\":\"P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2021-11-06T09:53:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/2021\\\/11\\\/06\\\/pildora-antiviral-evita-89-de-hospitalizaciones\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"P\u00edldora antiviral evita 89 % de hospitalizaciones\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\",\"name\":\"El Diario - Decano de la prensa nacional\",\"description\":\"El Diario - Decano de la prensa nacional\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#organization\",\"name\":\"El Diario - Decano de la prensa nacional\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/logo_ED.jpg\",\"contentUrl\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/logo_ED.jpg\",\"width\":272,\"height\":52,\"caption\":\"El Diario - Decano de la prensa nacional\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/eldiario.bolivia\\\/\",\"https:\\\/\\\/x.com\\\/eldiario_net\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/#\\\/schema\\\/person\\\/634255f275431248bb9faa38296b494a\",\"name\":\"Jeanette\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g\",\"caption\":\"Jeanette\"},\"sameAs\":[\"https:\\\/\\\/www.eldiario.net\\\/portal\"],\"url\":\"https:\\\/\\\/www.eldiario.net\\\/portal\\\/author\\\/jeanette\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/","og_locale":"es_ES","og_type":"article","og_title":"P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia","og_description":"Pfizer dio a conocer su nuevo candidato antiviral oral contra el covid-19 que actualmente se encuentra en investigaci\u00f3n. Seg\u00fan los primeros resultados, Paxlovid redujo en 89 % el riesgo de hospitalizaci\u00f3n o muerte en comparaci\u00f3n con el uso de placebos en adultos de alto riesgo no hospitalizados con coronavirus. En el ensayo realizado con 1,219 [&hellip;]","og_url":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/","og_site_name":"El Diario - Bolivia","article_publisher":"https:\/\/www.facebook.com\/eldiario.bolivia\/","article_published_time":"2021-11-06T09:53:22+00:00","author":"Jeanette","twitter_card":"summary_large_image","twitter_creator":"@eldiario_net","twitter_site":"@eldiario_net","twitter_misc":{"Escrito por":"Jeanette","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#article","isPartOf":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/"},"author":{"name":"Jeanette","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/person\/634255f275431248bb9faa38296b494a"},"headline":"P\u00edldora antiviral evita 89 % de hospitalizaciones","datePublished":"2021-11-06T09:53:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/"},"wordCount":120,"publisher":{"@id":"https:\/\/www.eldiario.net\/portal\/#organization"},"image":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#primaryimage"},"thumbnailUrl":"","articleSection":["Portada"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/","url":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/","name":"P\u00edldora antiviral evita 89 % de hospitalizaciones - El Diario - Bolivia","isPartOf":{"@id":"https:\/\/www.eldiario.net\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#primaryimage"},"image":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#primaryimage"},"thumbnailUrl":"","datePublished":"2021-11-06T09:53:22+00:00","breadcrumb":{"@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/www.eldiario.net\/portal\/2021\/11\/06\/pildora-antiviral-evita-89-de-hospitalizaciones\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.eldiario.net\/portal\/"},{"@type":"ListItem","position":2,"name":"P\u00edldora antiviral evita 89 % de hospitalizaciones"}]},{"@type":"WebSite","@id":"https:\/\/www.eldiario.net\/portal\/#website","url":"https:\/\/www.eldiario.net\/portal\/","name":"El Diario - Decano de la prensa nacional","description":"El Diario - Decano de la prensa nacional","publisher":{"@id":"https:\/\/www.eldiario.net\/portal\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eldiario.net\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.eldiario.net\/portal\/#organization","name":"El Diario - Decano de la prensa nacional","url":"https:\/\/www.eldiario.net\/portal\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/www.eldiario.net\/portal\/wp-content\/uploads\/2023\/07\/logo_ED.jpg","contentUrl":"https:\/\/www.eldiario.net\/portal\/wp-content\/uploads\/2023\/07\/logo_ED.jpg","width":272,"height":52,"caption":"El Diario - Decano de la prensa nacional"},"image":{"@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eldiario.bolivia\/","https:\/\/x.com\/eldiario_net"]},{"@type":"Person","@id":"https:\/\/www.eldiario.net\/portal\/#\/schema\/person\/634255f275431248bb9faa38296b494a","name":"Jeanette","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ea2118a5f7dad2b7138b1187a6b7ee55f160b9968b66013c3a3ef39dd7e5798?s=96&d=mm&r=g","caption":"Jeanette"},"sameAs":["https:\/\/www.eldiario.net\/portal"],"url":"https:\/\/www.eldiario.net\/portal\/author\/jeanette\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts\/41213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/comments?post=41213"}],"version-history":[{"count":0,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/posts\/41213\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/media?parent=41213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/categories?post=41213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eldiario.net\/portal\/wp-json\/wp\/v2\/tags?post=41213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}